| Literature DB >> 34927149 |
Hideaki Hasuo1, Hiroto Ishiki2, Yoshinobu Matsuda3, Hiromichi Matsuoka4, Shuji Hiramoto5, Junya Kinkawa6, Masanori Nojima7.
Abstract
Background: Because psychosomatic diseases are pathological conditions, it is difficult to identify their degrees. The armchair sign is a test used to assess voluntary muscle relaxation. Objective: We aimed to evaluate the usefulness of the armchair sign for the diagnosis of psychosomatic-prone myofascial pain syndrome (MPS) in patients with incurable cancer. Design: This was a secondary analysis of a prospective multicenter observational clinical study. Setting/Patients: Patients with incurable cancer who were referred to palliative care services at five institutions in Japan between March 2018 and December 2018.Entities:
Keywords: armchair sign; incurable cancer; myofascial pain syndrome; psychosomatic disease
Year: 2021 PMID: 34927149 PMCID: PMC8675228 DOI: 10.1089/pmr.2021.0033
Source DB: PubMed Journal: Palliat Med Rep ISSN: 2689-2820
FIG. 1.Evaluation of the armchair sign.
Demographic and Clinical Characteristics of Study Participants
| Age (years), mean (SD) | 60.8 (12.4) |
| Gender, | |
| Male | 42 (41.6) |
| Female | 59 (58.4) |
| Primary cancer site, | |
| Lung | 31 (30.7) |
| Gastrointestinal | 25 (24.7) |
| Liver, pancreas, biliary system | 15 (14.8) |
| Gynecological | 11 (10.9) |
| Head and neck | 5 (5.0) |
| Others | 14 (13.9) |
| ECOG PS, | |
| 0–2 | 52 (51.5) |
| 3–4 | 49 (48.5) |
| Anticancer treatment, | |
| No | 51 (50.5) |
| Yes | 50 (49.5) |
| Chemotherapy | 45 (41.6) |
| Radiotherapy | 15 (14.9) |
| Medical devices, | |
| No | 65 (64.4) |
| Yes | 36 (35.6) |
| Central venous catheter | 2 (1.9) |
| Central venous port | 15 (14.9) |
| Nasogastric tube | 2 (1.9) |
| Nephrostomy catheter | 2 (1.9) |
| Urethral catheter | 5 (5.0) |
| Stoma | 4 (4.0) |
| Others | 6 (6.0) |
ECOG PS, Eastern Cooperative Oncology Group performances status; SD, standard deviation.
Comparison Between Demographic Information, Clinical Characteristics, and Measures of the Psychosomatic-Prone Myofascial Trigger Syndrome and Control Groups
| Psychosomatic-prone MPS group (n = 27) | Nonpsychosomatic-prone MPS group (n = 17) |
| |
|---|---|---|---|
| Age (years), mean (SD) | 60.7 (12.6) | 60.5 (12.6) | 0.982 |
| Gender (female), | 14 (51.9) | 10 (58.8) | 0.405 |
| ECOG PS, | |||
| 0–2 | 10 (37.0) | 8 (47.1) | 0.319 |
| 3–4 | 17 (63.0) | 9 (52.9) | |
| Anticancer treatment (yes), | 12 (44.4) | 6 (35.3) | 0.237 |
| Medical devices (yes), | 7 (25.9) | 6 (35.3) | 0.227 |
| Site of MPS, | |||
| Upper back | 17 (63.0) | 8 (47.1) | 0.319 |
| Lower back | 10 (37.0) | 9 (52.9) | |
| Pain NRS score of MPS, mean (SD) | 60.7 (12.6) | 60.9 (12.4) | 0.188 |
| Armchair sign, | |||
| (+) | 11 (40.7) | 0 (0) | <0.001 |
| (−) | 16 (59.3) | 17 (100.0) | |
MPS, myofascial pain syndrome; NRS, numerical rating scale.
FIG. 2.Receiver operating characteristic curve of the armchair sign with or without psychosomatic-prone myofascial pain syndrome.